Evidence map›Paper›PMID 40597309›Full record

ArticleBreast cancer research : BCR2025

Long-term weight change among breast cancer patients treated with chemotherapy: a longitudinal study over 13 years.

Mathilde His, Iris Baggio, Sylvie Chabaud, Louis Tassy, Olivier Trédan, Béatrice Fervers, Olivia Pérol

Abstract read
In one paragraph

Article in Breast cancer research : BCR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mathilde HisPrevention Cancer Environment Department, Centre Léon Bérard, 28 rue Laënnec, Lyon, 69008, France. Mathilde.his@lyon.unicancer.fr.
Iris BaggioPrevention Cancer Environment Department, Centre Léon Bérard, 28 rue Laënnec, Lyon, 69008, France.
Sylvie ChabaudDepartment of Biostatistics - Clinical Resarch Unit, Centre Léon Bérard, 28 rue Laënnec, Lyon, 69008, France.
Louis TassyInstitute Paoli-Calmette, Marseille, 13009, France.
Olivier TrédanDepartment of Medical Oncology, Centre Léon Bérard, Lyon, France.
Béatrice FerversPrevention Cancer Environment Department, Centre Léon Bérard, 28 rue Laënnec, Lyon, 69008, France.
Olivia PérolPrevention Cancer Environment Department, Centre Léon Bérard, 28 rue Laënnec, Lyon, 69008, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWeight gain during chemotherapy is frequently reported in breast cancer patients and adversely impacts survival and quality of life. However, weight change over the long term and its determinants in breast cancer patients who received chemotherapy remain unclear. This study aimed to characterize weight change over 13 years among French breast cancer patients diagnosed with early-stage breast cancer who received adjuvant chemotherapy.

methodsWe examined weight change over 13 years in a cohort of 267 early breast cancer patients diagnosed between 2004 and 2006 and treated with adjuvant chemotherapy. Yearly weight measures were obtained from medical records, or from questionnaires when not available from medical records. We compared weight at each time using analysis of variance for repeated data based on mixed-effect models, and examined clinical and individual factors as potential determinants of weight change over the study period.

resultsMore than one third of women experienced weight gain > 5% of their initial body weight following initiation of adjuvant chemotherapy (34.6%, 36.0%, 41.6%, and 37.4% at years 1, 5, 10, 13, respectively). A statistically significant weight gain occurred during the first year after initiation of chemotherapy (estimated mean gain: 1.80 kg; 95% confidence interval (0.52-3.1) kg) and was maintained for up to 13 years (P-value for overall effect of time on weight < 0.001). This weight gain was observed only for women with an initial BMI < 25 kg/m². Type of chemotherapy, use of hormone therapy, age at inclusion, menopausal status, or physical activity level at initial visit did not show statistically significant association with weight change.

conclusionsThese results emphasize the need to improve our understanding of weight change and its determinants and to develop effective intervention strategies to prevent weight gain for breast cancer patients during the first year of treatment.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsWeight GainAdultAgedBody Mass IndexBody WeightChemotherapy, AdjuvantFemaleHumansLongitudinal StudiesMiddle AgedQuality of LifeBreast cancerChemotherapyDeterminantsLongitudinal studyWeight change

Identifiers

PMID40597309
PMCPMC12211758

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.